The GRAPPA-OMERACT psoriatic arthritis working group at the 2018 annual meeting: Report and plan for completing the core outcome measurement set

Ying Ying Leung; Ana Maria Orbai; Alexis Ogdie; Laura C. Coates; Maarten De Wit; Kristina Callis Duffin; Lihi Eder; Dafna D. Gladman; Niti Goel; Philip J. Mease; Vibeke Strand; Oliver FitzGerald; William Tillett

doi:10.3899/JRHEUM.190122

The GRAPPA-OMERACT psoriatic arthritis working group at the 2018 annual meeting: Report and plan for completing the core outcome measurement set

Ying Ying Leung, Ana Maria Orbai, Alexis Ogdie, Laura C. Coates, Maarten De Wit, Kristina Callis Duffin, Lihi Eder, Dafna D. Gladman, Niti Goel, Philip J. Mease, Vibeke Strand, Oliver FitzGerald, William Tillett

School of Medicine

Research output: Contribution to journal › Article › peer-review

5 Scopus citations

Abstract

The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Working Group reported at the 2018 GRAPPA annual meeting on the outcome of the OMERACT 2018 Conference in Terrigal, Australia. The working group presented the endorsement of the 66/68 joint count for the assessment of peripheral arthritis and the provisional endorsement of the PsA Impact of Disease 12 questionnaire for the assessment of PsA-specific health-related quality of life in PsA randomized controlled trials and observational studies. In this report, the group presents its plan to seek OMERACT endorsement for outcome measures that address the domains of MSK disease activity for enthesitis and dactylitis, physical function, fatigue, and structural damage following the OMERACT Filter 2.1 methodology.

Original language	English (US)
Pages (from-to)	33-37
Number of pages	5
Journal	Journal of Rheumatology
Volume	95
DOIs	https://doi.org/10.3899/JRHEUM.190122
State	Published - Jun 1 2018

Keywords

GRAPPA
Omeract
Outcome Measures
Psoriasis
Psoriatic Arthritis

ASJC Scopus subject areas

Rheumatology
Immunology and Allergy
Immunology

Access to Document

10.3899/JRHEUM.190122

Cite this

Leung, Y. Y., Orbai, A. M., Ogdie, A., Coates, L. C., De Wit, M., Duffin, K. C., Eder, L., Gladman, D. D., Goel, N., Mease, P. J., Strand, V., FitzGerald, O., & Tillett, W. (2018). The GRAPPA-OMERACT psoriatic arthritis working group at the 2018 annual meeting: Report and plan for completing the core outcome measurement set. Journal of Rheumatology, 95, 33-37. https://doi.org/10.3899/JRHEUM.190122

Leung, YY, Orbai, AM, Ogdie, A, Coates, LC, De Wit, M, Duffin, KC, Eder, L, Gladman, DD, Goel, N, Mease, PJ, Strand, V, FitzGerald, O & Tillett, W 2018, 'The GRAPPA-OMERACT psoriatic arthritis working group at the 2018 annual meeting: Report and plan for completing the core outcome measurement set', Journal of Rheumatology, vol. 95, pp. 33-37. https://doi.org/10.3899/JRHEUM.190122

@article{af5e529166e14daa83453f9bba27f641,

title = "The GRAPPA-OMERACT psoriatic arthritis working group at the 2018 annual meeting: Report and plan for completing the core outcome measurement set",

abstract = "The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Working Group reported at the 2018 GRAPPA annual meeting on the outcome of the OMERACT 2018 Conference in Terrigal, Australia. The working group presented the endorsement of the 66/68 joint count for the assessment of peripheral arthritis and the provisional endorsement of the PsA Impact of Disease 12 questionnaire for the assessment of PsA-specific health-related quality of life in PsA randomized controlled trials and observational studies. In this report, the group presents its plan to seek OMERACT endorsement for outcome measures that address the domains of MSK disease activity for enthesitis and dactylitis, physical function, fatigue, and structural damage following the OMERACT Filter 2.1 methodology.",

keywords = "GRAPPA, Omeract, Outcome Measures, Psoriasis, Psoriatic Arthritis",

author = "Leung, {Ying Ying} and Orbai, {Ana Maria} and Alexis Ogdie and Coates, {Laura C.} and {De Wit}, Maarten and Duffin, {Kristina Callis} and Lihi Eder and Gladman, {Dafna D.} and Niti Goel and Mease, {Philip J.} and Vibeke Strand and Oliver FitzGerald and William Tillett",

year = "2018",

month = jun,

day = "1",

doi = "10.3899/JRHEUM.190122",

language = "English (US)",

volume = "95",

pages = "33--37",

journal = "Journal of Rheumatology",

issn = "0315-162X",

publisher = "Journal of Rheumatology",

}

TY - JOUR

T1 - The GRAPPA-OMERACT psoriatic arthritis working group at the 2018 annual meeting

T2 - Report and plan for completing the core outcome measurement set

AU - Leung, Ying Ying

AU - Orbai, Ana Maria

AU - Ogdie, Alexis

AU - Coates, Laura C.

AU - De Wit, Maarten

AU - Duffin, Kristina Callis

AU - Eder, Lihi

AU - Gladman, Dafna D.

AU - Goel, Niti

AU - Mease, Philip J.

AU - Strand, Vibeke

AU - FitzGerald, Oliver

AU - Tillett, William

PY - 2018/6/1

Y1 - 2018/6/1

N2 - The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Working Group reported at the 2018 GRAPPA annual meeting on the outcome of the OMERACT 2018 Conference in Terrigal, Australia. The working group presented the endorsement of the 66/68 joint count for the assessment of peripheral arthritis and the provisional endorsement of the PsA Impact of Disease 12 questionnaire for the assessment of PsA-specific health-related quality of life in PsA randomized controlled trials and observational studies. In this report, the group presents its plan to seek OMERACT endorsement for outcome measures that address the domains of MSK disease activity for enthesitis and dactylitis, physical function, fatigue, and structural damage following the OMERACT Filter 2.1 methodology.

AB - The Group for Research and Assessment of Psoriasis and Psoriatic Arthritis (GRAPPA)-Outcome Measures in Rheumatology (OMERACT) Psoriatic Arthritis (PsA) Working Group reported at the 2018 GRAPPA annual meeting on the outcome of the OMERACT 2018 Conference in Terrigal, Australia. The working group presented the endorsement of the 66/68 joint count for the assessment of peripheral arthritis and the provisional endorsement of the PsA Impact of Disease 12 questionnaire for the assessment of PsA-specific health-related quality of life in PsA randomized controlled trials and observational studies. In this report, the group presents its plan to seek OMERACT endorsement for outcome measures that address the domains of MSK disease activity for enthesitis and dactylitis, physical function, fatigue, and structural damage following the OMERACT Filter 2.1 methodology.

KW - GRAPPA

KW - Omeract

KW - Outcome Measures

KW - Psoriasis

KW - Psoriatic Arthritis

UR - http://www.scopus.com/inward/record.url?scp=85067131882&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85067131882&partnerID=8YFLogxK

U2 - 10.3899/JRHEUM.190122

DO - 10.3899/JRHEUM.190122

M3 - Article

C2 - 31154402

AN - SCOPUS:85067131882

SN - 0315-162X

VL - 95

SP - 33

EP - 37

JO - Journal of Rheumatology

JF - Journal of Rheumatology

ER -

The GRAPPA-OMERACT psoriatic arthritis working group at the 2018 annual meeting: Report and plan for completing the core outcome measurement set

Abstract

Keywords

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this